202 related articles for article (PubMed ID: 24447548)
1. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract][Full Text] [Related]
2. Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.
Yonemori K; Hasegawa T; Shimizu C; Shibata T; Matsumoto K; Kouno T; Ando M; Katsumata N; Fujiwara Y
Pathol Res Pract; 2006; 202(10):705-12. PubMed ID: 16889904
[TBL] [Abstract][Full Text] [Related]
3. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
[TBL] [Abstract][Full Text] [Related]
5. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
Kleer CG; Giordano TJ; Braun T; Oberman HA
Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
[TBL] [Abstract][Full Text] [Related]
6. p53 and Ki-67 expression as prognostic factors in cystosarcoma phyllodes.
Erhan Y; Zekioglu O; Ersoy O; Tugan D; Aydede H; Sakarya A; Kapkaç M; Ozdemir N; Ozbal O; Erhan Y
Breast J; 2002; 8(1):38-44. PubMed ID: 11856160
[TBL] [Abstract][Full Text] [Related]
7. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.
Shpitz B; Bomstein Y; Sternberg A; Klein E; Tiomkin V; Kaufman A; Groisman G; Bernheim J
J Surg Oncol; 2002 Feb; 79(2):86-92. PubMed ID: 11815995
[TBL] [Abstract][Full Text] [Related]
9. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
Tan PH
Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
[TBL] [Abstract][Full Text] [Related]
10. Periductal stromal tumor: a rare lesion with low-grade sarcomatous behavior.
Burga AM; Tavassoli FA
Am J Surg Pathol; 2003 Mar; 27(3):343-8. PubMed ID: 12604890
[TBL] [Abstract][Full Text] [Related]
11. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases.
Niezabitowski A; Lackowska B; Rys J; Kruczak A; Kowalska T; Mitus J; Reinfuss M; Markiewicz D
Breast Cancer Res Treat; 2001 Jan; 65(1):77-85. PubMed ID: 11245343
[TBL] [Abstract][Full Text] [Related]
12. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.
Kucuk U; Bayol U; Pala EE; Cumurcu S
Indian J Pathol Microbiol; 2013; 56(2):129-34. PubMed ID: 24056649
[TBL] [Abstract][Full Text] [Related]
13. [Phyllodes tumor of the breast: clinicopathologic analysis of 22 cases].
Velázquez-Dohorn M; Gamboa-Domínguez A; Medina-Franco H
Rev Invest Clin; 2013; 65(3):214-20. PubMed ID: 23877808
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the treatment and prognosis of recurrent breast phyllodes tumor].
Fang Y; Gao JD; Tian YT; Xie YQ; Zhen S
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):72-4. PubMed ID: 19538877
[TBL] [Abstract][Full Text] [Related]
16. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
17. Phyllodes tumor: clinicopathologic review of 60 patients and flow cytometric analysis in 30 patients.
Keelan PA; Myers JL; Wold LE; Katzmann JA; Gibney DJ
Hum Pathol; 1992 Sep; 23(9):1048-54. PubMed ID: 1325408
[TBL] [Abstract][Full Text] [Related]
18. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
[TBL] [Abstract][Full Text] [Related]
19. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations.
Grimes MM
Mod Pathol; 1992 May; 5(3):232-9. PubMed ID: 1323101
[TBL] [Abstract][Full Text] [Related]
20. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
